CDC Assessing Accuracy Of SARS Diagnostis; Future Virus Mutations Expected
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Disease Control & Prevention has begun production and widespread distribution of reagents for the diagnosis of the Severe Acute Respiratory Syndrome (SARS) virus, Gen-Probe Chief Scientist Daniel Kacian MD/PhD explained during a Merrill Lynch conference call April 10